Regulatory Strategy
Build a regulatory path that reflects the product, evidence, business objective, and real operating constraints.
- Product definition, intended use, and claims strategy
- FDA pathway and predicate assessment
- Q-Submission and agency-interaction strategy
- 510(k), de novo, PMA, and CLIA-waiver planning
- Submission readiness and regulatory risk review